Opioid Cross-Reactivity and Safety

Introduction to Opioid Classifications

Morphine is a natural mu-opioid receptor agonist and weak kappa receptor agonist, while fentanyl is a synthetic highly lipid-soluble mu-opioid receptor agonist with a different chemical structure, according to the National Comprehensive Cancer Network 1, 2

Fentanyl is often the treatment of choice for patients with poor tolerance to morphine, as recommended by the National Comprehensive Cancer Network 1, 2
Patients with renal insufficiency should avoid morphine due to the accumulation of renally cleared metabolites that may cause neurologic toxicity, as suggested by the National Comprehensive Cancer Network 1, 3
Fentanyl may be preferred in patients with constipation issues, as it has shown lower rates of constipation compared to oral morphine regimens, according to the National Comprehensive Cancer Network 1

Fentanyl can be administered via multiple routes, including parenteral, spinal, transdermal, transmucosal, buccal, and intranasal, as stated by the National Comprehensive Cancer Network 1, 2
When converting from morphine to fentanyl, reduce the calculated equianalgesic dose by 25%-50% to account for incomplete cross-tolerance between different opioids, as recommended by the National Comprehensive Cancer Network 3, 4

Avoid using mixed agonist-antagonist opioids in patients on pure agonists like morphine or fentanyl, as this could precipitate withdrawal in opioid-dependent patients, according to the National Comprehensive Cancer Network 3, 5